A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis

Journal of the American Academy of Dermatology

Volumn 55, Issue 1, 2006, Pages 40-46

  Belsito, Donald ^a   Wilson, David C ^b   Warshaw, Erin ^c,d   Fowler, Joseph ^e   Ehrlich, Alison ^f   Anderson, Bryan ^g   Strober, Bruce E ^h   Willetts, Jennifer ⁱ   Rutledge, Edward S ⁱ  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b The Education and Research Foundation Inc   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF LOUISVILLE   (United States)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

^g PENNSYLVANIA STATE UNIVERSITY   (United States)

^h NEW YORK UNIVERSITY   (United States)

ⁱ ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICKEL; PLACEBO; TACROLIMUS;

ADOLESCENT; ADULT; APPLICATION SITE BURNING; APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE PAIN; APPLICATION SITE PRURITUS; APPLICATION SITE REACTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN ALLERGY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DERMATITIS, ALLERGIC CONTACT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NICKEL; OINTMENTS; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 33744993904     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.03.025     Document Type: Article

References (10)

1. Marks Jr. J.G., Elsner P., and DeLeo V.A. Contact and occupational dermatology. 3rd ed. (2002), Mosby, St Louis
2. Diepgen T.L., and Coenraads P.J. The epidemiology of occupational contact dermatitis. Int Arch Occup Environ Health 72 (1999) 496-506
3. Martin B.G. Contact dermatitis: evaluation and treatment. J Am Osteopath Assoc 99 Suppl (1999) S11-S14
4. Boucher M. Tacrolimus ointment for the treatment of atopic dermatitis. Issues Emerg Health Technol 19 (2001) 1-4
5. Belsito D.V. Allergic contact dermatitis. In: Freedberg I.M., Eisen A.Z., Wolff K., Austen K.F., Goldsmith L.A., and Katz S.I. (Eds). Fitzpatrick's dermatology in general medicine. 5th ed. (1999), McGraw Hill, New York 1147-1161
6. Leung D.Y.M. Cellular and immunologic mechanisms in atopic dermatitis. J Am Acad Dermatol 44 Suppl (2001) S1-S12
7. Bekersky I., Fitzsimmons W., Tanase A., Maher R.M., Hodosh E., and Lawrence I. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J Am Acad Dermatol 44 Suppl (2001) S17-S27
8. Reitamo S., Rissanen J., Remitz A., Granlund H., Erkko P., Elg P., et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 111 (1998) 396-398
9. Saripalli Y.V., Gadzia J.E., and Belsito D.V. Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis. J Am Acad Dermatol 49 (2003) 477-482
10. Begg C., Cho M., Eastwood S., Horton R., Moher D., Olkin I., et al. Improving the quality of reporting of randomized controlled trials. JAMA 276 (1996) 937-939